Clinical Trials Directory

Trials / Unknown

UnknownNCT04907123

Systematic Escalation of diuREtics With Natriuresis in Heart Failure Patients: SERENA Trial

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
198 (estimated)
Sponsor
University of Turin, Italy · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Not accepted

Summary

The present is a multicenter, prospective, randomized, open-label, blinded end-point trial aiming to investigate the clinical benefit of a stepwise, natriuresis-driven diuretic strategy versus standard diuretic treatment in patients with acute decompensated heart failure with reduced ejection fraction (HFrEF) and low early urinary sodium excretion. The study will focus on patients at increased risk of resistance to diuretic therapy. In particular, patients admitted to the emergency department and cardiac intensive care unit due to an on-chronic or de-novo acute decompensated HF episode with a predominantly "wet" profile and low early spot urinary sodium (UNa+) excretion will be considered. Spot natriuresis is a low-cost, non-demanding laboratory test in use to identify diuretic-resistant patients with an inherent poor prognosis. Whether the early identification of diuretic resistant patients and the consequent more aggressive treatment may lead to a better outcome has not been demonstrated by randomized studies. This trial aims to assess if an intensive stepwise diuretic approach guided by systematic urinary output assessment including natriuresis evaluation versus a standard diuretic strategy based on urinary output alone effectively leads to faster euvolemia achievement and better prognosis in a real-world setting.

Conditions

Interventions

TypeNameDescription
OTHERIntensive sodiuria-guided diuretic treatmentIntensive stepwise diuretic treatment based on combined diuresis and urinary sodium assessment
OTHERStandard diuretic treatmentStepwise diuretic therapy based on diuresis assessment

Timeline

Start date
2021-10-01
Primary completion
2024-10-01
Completion
2025-01-01
First posted
2021-05-28
Last updated
2021-05-28

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT04907123. Inclusion in this directory is not an endorsement.